Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Daiichi Sankyo.
Real, source-linked trial activity for Daiichi Sankyo: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 8, 2026. Source-linked, daily-refreshed.
N/A 2
Newest Daiichi Sankyo trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Medical Access Program for Valemetostat Tosylate (DS 3201b) For The Tr | N/A | TEMPORARILY_NOT_AVAILABLE | ↗ |
| 1d ago | Medical Access Program for DS-9606a (DS-9606) in Patients With Advance | N/A | TEMPORARILY_NOT_AVAILABLE | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Daiichi Sankyo (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.